Skip to main content
. 2021 Sep 30;13(19):4948. doi: 10.3390/cancers13194948

Table 4.

Number (percentage) of participants with clinically meaningful improvement based on fatigue assessments.

Outcome T0-T1 a T0-T2 a T0-T3 a
No. (%) No. (%) No. (%)
BWL DWL p b OR c BWL DWL p b OR c BWL DWL p b OR c
VAS fatigue
Improved 34 (42) 41 (55) 0.11 0.60 25 (35) 37 (52) 0.04 0.50 24 (33) 27 (39) 0.48 0.78
Not improved 47 (58) 34 (45) 46 (65) 34 (48) 49 (67) 43 (61)
n 81 75 71 71 73 70
MFI general fatigue
Improved 49 (60) 47 (63) 0.71 0.89 35 (49) 37 (52) 0.68 0.87 36 (49) 40 (57) 0.31 0.71
Not improved 33 (40) 28 (37) 37 (51) 34 (48) 38 (51) 30 (43)
n 82 75 72 71 74 70
WSAS
Improved 33 (40) 26 (35) 0.47 1.27 31 (43) 27 (39) 0.59 1.20 31 (42) 29 (41) 0.96 1.02
Not improved 49 (60) 49 (65) 41 (57) 43 (61) 43 (58) 41 (59)
n 82 75 72 70 74 70

Note: shading in the table represents the distinction between variables. Abbreviations: MFI, Multidimensional Fatigue Inventory; OR, odds ratio; VAS, visual analogue scale; WSAS, Work and Social Adjustment Scale. a T0, baseline; T1, post-intervention; T2, 3 months after light therapy; T3, 9 months after light therapy. b p value of the Pearson chi-square test. c Odds ratios of 1.5 were considered small, 2.0 as moderate, and 3.0 as large.